Humacyte, Inc. announced the appointment of Shamik J. Parikh, M.D., as Chief Medical Officer. In this role, Dr. Parikh will lead the company's global clinical development strategy, including oversight of the preclinical and clinical development, clinical operations, and medical affairs functions. Dr. Parikh brings more than two decades of leadership experience in academia and at global pharmaceutical companies, where he oversaw clinical and drug strategy, research and development, and product launches across multiple therapeutic areas.

He most recently served as Vice President, Head of Patient Safety Center for Excellence at AstraZeneca, where he led the enterprise-wide patient safety efforts, oversaw the development and execution of strategic initiatives and global pharmacovigilance of multiple products, and served as a core member of the AstraZeneca Executive Safety Board.